Resultados: 8

    AGA clinical practice guideline on the role of biomarkers for the management of Crohn’s Disease

    Gastroenterology; 6 (165), 2023
    Biomarkers are used frequently for evaluation and monitoring of patients with Crohn’s disease (CD). This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions about the use of biomarkers for the management of CD. A multidisciplinary panel of content ...

    AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis

    Gastroenterology; 164 (3), 2023
    Biomarkers are used frequently for noninvasive monitoring and treatment decision making in the management of patients with ulcerative colitis (UC). This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions about the use of biomarkers for the managemen...

    AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity

    Gastroenterology; 163 (5), 2022
    Pharmacological management of obesity improves outcomes and decreases the risk of obesity-related complications. This American Gastroenterological Association guideline is intended to support practitioners in decisions about pharmacological interventions for overweight and obesity. A multidisciplinary pa...

    AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea

    Gastroenterology; 163 (1), 2022
    Background & aims: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder associated with significant disease burden. This American Gastroenterological Association Guideline is intended to support practitioners in decisions about the use of medications for the pharmacological man...

    AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation

    Gastroenterology; 163 (1), 2022
    Irritable bowel syndrome (IBS) is a common disorder of gut–brain interaction associated with significant disease burden. This American Gastroenterological Association guideline is intended to support practitioners in decisions about the use of medications for the pharmacological management of IBS-C and...

    AGA rapid review and guideline for SARS-CoV2 testing and endoscopy post-vaccination: 2021 update

    Gastroenterology; 161 (3), 2021
    This guideline provides updated recommendations on the role of preprocedure testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in individuals undergoing endoscopy in the post-vaccination period and replaces the prior guideline from the American Gastroenterological Association (AGA) (...

    Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

    Develop evidence-based rapid guidelines intended to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19....

    AGA Institute Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic

    Multiple questions have been raised regarding the gastrointestinal and liver manifestations of COVID-19 infection, and implications of SARS-CoV-2 infection on gastrointestinal endoscopy. A joint society statement of the American Gastroenterological Association (AGA), the American Association for the Stud...